Kindred Biosciences, Inc. announced that its restructuring includes the departure of Denise M. Bevers as company’s President and Chief Operating Officer. Ms. Bevers is currently anticipated to terminate her employment on July 31, 2020, although she will remain on company’s board of directors and will be entitled to receive compensation on the same basis as company’s other non-employee directors.